Skip to main content

AVANZANDO EN VACUNAS SEGURAS CONTRA LA BRUCELOSIS OVINA: EFICACIA DE CANDIDATOS VACUNALES MEJORADOS DE B. MELITENSIS Y B. OVIS Y MODELOS IN VITRO INNOVADORES

PID2023-146797OB-C32

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2023
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre CENTRO DE INVESTIGACION Y TECNOLOGIA AGROALIMENTARIA DE ARAGON (CITA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Conjunctival administration of H38ΔwbkF rough vaccine as an effective strategy to protect against Brucella ovis infection while minimizing serological interference

  • Lopez, Nerea
  • Andrés-Barranco, Sara
  • Miguel, M. Jesús de
  • Zúñiga-Ripa, Amaia
  • Elizalde-Bielsa, Aitor
  • Salvador-Bescós, Miriam
  • Iriarte, Maite
  • Barberán, Montserrat
  • Blasco, José María
  • Moriyón, Ignacio
  • Conde-Álvarez, Raquel
  • Muñoz, Pilar M.
Sheep brucellosis is a reproductive disease caused by Brucella melitensis and B. ovis, Gram-negative bacteria that differ in surface antigens: B. melitensis carries a smooth (S) lipopolysaccharide (LPS) with a characteristic O-polysaccharide (O-PS), while B. ovis bears a rough (R) LPS lacking O-PS. Only the former is zoonotic and of public health concern, but both cause significant economic losses, thus requiring effective vaccines. The sole vaccine available, B. melitensis Rev1, protects against both infections but induces antibodies detected by S-LPS-based tests used for B. melitensis surveillance. Since controlling this zoonotic species is a priority, Rev1 is banned in B. melitensis-free areas. Consequently, B. ovis (detected by R-LPS-based tests) remains endemic or re-emerges, and an R brucellosis vaccine is needed. Previously, we demonstrated that subcutaneous vaccination with B. melitensis R mutant H38ΔwbkF protects rams against B. ovis similarly to Rev1, without interfering in the official S-LPS-based Rose Bengal and Complement Fixation tests. However, H38ΔwbkF elicits R-LPS antibodies that interfere with B. ovis tests. Here, we explored two strategies to minimize this interference: (i) altering H38ΔwbkF relevant diagnostic epitopes by constructing wadB and wadC mutants deleted in sugars of the R-LPS core tetrasaccharide branch; and (ii) administering H38ΔwbkF conjunctivally, a route known to reduce antibody responses to S brucellosis vaccines. While the core-defective mutants were over-attenuated and failed to protect mice, the conjunctival route preserved H38ΔwbkF efficacy in rams and significantly reduced serological interference. Conjunctival H38ΔwbkF vaccine is thus a suitable tool for B. ovis eradication in B. melitensis-free areas.
citaREA. Repositorio Institucional del CITA
Publication Artículo científico (JournalArticle)

Disruption of the Nitric Oxide Reductase Operon via norD Deletion Does Not Affect Brucella abortus 2308W Virulence

  • Rasheed, Faisal
  • Zúñiga Ripa, Amaia
  • Salvador Bescós, Miriam
  • Irshad, Hamid
  • Peña Villafruela, Raquel
  • Muñoz Álvaro, Pilar María
  • Miguel López, María Jesús de
  • Ali, Qurban
  • Conde Álvarez, Raquel
  • Khan, Saeed-ul-Hassan
Brucella are intracellular pathogens that use flexible respiratory strategies to adapt to oxygen-limited conditions. The nor operon encodes components of nitric oxide reductase (Nor), which are involved in denitrification and nitric oxide (NO) detoxification. In this study, the role of the norD gene in nitrate-dependent respiration, resistance to nitrosative stress, and intracellular persistence in B. abortus was evaluated. A non-polar ΔnorD mutant was generated in strain 2308W and its survival and growth under aerobic and anaerobic conditions, with and without nitrate, as well as its tolerance to NO donors, were analyzed. In addition, its behavior was evaluated in activated and non-activated murine RAW264.7 and human THP-1 macrophages and in a murine infection model. The deletion of norD did not affect viability or growth under any of the conditions tested, nor did it alter resistance to NO in vitro or within activated macrophages. Furthermore, the mutant showed virulence comparable to the wild-type strain in BALB/c mice. These results contrast with those described for other Brucella species, suggesting that norD is dispensable in B. abortus 2308W virulence and that in the Brucella genus, there are species-specific differences in the role of the nor operon during infection., Esta investigación ha sido financiada por MCIN/AEI/10.1303910.13039/501100011033 y FEDER, UE en el marco de los proyectos PID2023-146797OB-C31, PID2023-146797OB-C32, PID2019-107601RB-C31 y PID2019-107601RA-C32. La estancia de F.R. en la Universidad de Navarra fue financiada por la Comisión de Educación Superior de Pakistán. R.P.-V. es beneficiario de la beca de doctorado financiada por PREP2023-000737. El trabajo de P.M.M. y M.J.d.M. (CITA) también contó con el apoyo del Gobierno de Aragón (Grupo de Investigación A21_23R)., Si
citaREA. Repositorio Institucional del CITA
Publication

Conjunctival administration of H38ΔwbkF rough vaccine as an effective strategy to protect against Brucella ovis infection while minimizing serological interference

  • López Fernández, Nerea
  • Andrés Barranco, Sara
  • Miguel López, María Jesús de
  • Zúñiga Ripa, Amaia
  • Elizalde Bielsa, Aitor
  • Salvador Bescós, Miriam
  • Iriarte, Maite
  • Barberán Pelegrín, Montserrat
  • Blasco Martínez, José María
  • Moriyón Uria, Ignacio
  • Conde Álvarez, Raquel
  • Muñoz Álvaro, Pilar María
Sheep brucellosis is a reproductive disease caused by Brucella melitensis and B. ovis, Gram-negative bacteria that differ in surface antigens: B. melitensis carries a smooth (S) lipopolysaccharide (LPS) with a characteristic O-polysaccharide (O-PS), while B. ovis bears a rough (R) LPS lacking O-PS. Only the former is zoonotic and of public health concern, but both cause significant economic losses, thus requiring effective vaccines. The sole vaccine available, B. melitensis Rev1, protects against both infections but induces antibodies detected by S-LPS-based tests used for B. melitensis surveillance. Since controlling this zoonotic species is a priority, Rev1 is banned in B. melitensis-free areas. Consequently, B. ovis (detected by R-LPS-based tests) remains endemic or re-emerges, and an R brucellosis vaccine is needed. Previously, we demonstrated that subcutaneous vaccination with B. melitensis R mutant H38ΔwbkF protects rams against B. ovis similarly to Rev1, without interfering in the official S-LPS-based Rose Bengal and Complement Fixation tests. However, H38ΔwbkF elicits R-LPS antibodies that interfere with B. ovis tests. Here, we explored two strategies to minimize this interference: (i) altering H38ΔwbkF relevant diagnostic epitopes by constructing wadB and wadC mutants deleted in sugars of the R-LPS core tetrasaccharide branch; and (ii) administering H38ΔwbkF conjunctivally, a route known to reduce antibody responses to S brucellosis vaccines. While the core-defective mutants were over-attenuated and failed to protect mice, the conjunctival route preserved H38ΔwbkF efficacy in rams and significantly reduced serological interference. Conjunctival H38ΔwbkF vaccine is thus a suitable tool for B. ovis eradication in B. melitensis-free areas., Esta investigación se ha llevado a cabo en el marco de los proyectos PID2023-146797OB-C31, PID2023-146797OB-C32, PID2019-107601RB-C31 y PID2019-107601RA-C32 financiados por MCIN/AEI/10.1303910.13039/501100011033 y por el FEDER, UE. El trabajo de P.M.M., S.A.B. y M.J.d.M. (CITA) también contó con el apoyo del Gobierno de Aragón (Grupo de Investigación A21_23R). N.L. fue beneficiario de la beca de doctorado financiada por PRE2020-093859., No
citaREA. Repositorio Institucional del CITA
Publication

Conjunctival administration of H38ΔwbkF rough vaccine as an effective strategy to protect against Brucella ovis infection while reducing the diagnostic interference of vaccine antibodies

  • López Fernández, Nerea
  • Andrés Barranco, Sara
  • Miguel López, María Jesús de
  • Salvador Bescós, M.
  • Zúñiga Ripa, Amaia
  • Iriarte, Maite
  • Blasco Martínez, José María
  • Moriyón Uria, Ignacio
  • Conde Álvarez, Raquel
  • Muñoz Álvaro, Pilar María
AIM OF THIS WORK: To evaluate the use of the conjunctival route as a strategy to reduce the persistence of H38ΔwbkF vaccine antibodies while maintaining protection against B. ovis., Research supported by MCIN/AEI (projects PID2023-146797OB-C31, PID2023-146797OB-C32, PID2019-107601RB-C31 and PID2019107601RA-C32), Aragón Goverment (A23-21R) and REPRODIVAC / Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact from the EU Horizon research and innovation program under Grant Agreement No. 101060313. Acknowledgements: Sara Serrano for her excellent technical assistant.